Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -106 | -457 | -211 | -3 | -25 |
| Purchase Of Investment | -300 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -13,666 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-14,072 | $-457 | $-211 | $-3 | $-25 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26,881 | 9,120 | 135 | 5,066 | 10,021 |
| Common Stock Repurchased | -1,625 | -503 | -10 | -313 | -1,231 |
| Other Financing Activity | -145 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $25,111 | $8,617 | $125 | $4,753 | $8,790 |
| Exchange Rate Effect | -9 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,662 | 3,147 | 9,940 | 7,074 | 1,476 |
| End Cash Position | 6,942 | 6,181 | 3,147 | 9,940 | 7,074 |
| Net Cash Flow | $5,290 | $3,034 | $-6,793 | $2,866 | $5,598 |
| Free Cash Flow | |||||
| Capital Expenditure | -106 | -458 | -211 | -5 | -27 |
| Free Cash Flow | -106 | -458 | -211 | -5 | -27 |